Biotechnology company Bio-Works reports increased revenue in the second quarter compared with the same period the previous year. The operating loss narrowed.Revenue rose to SEK 20.0 million (13.1).Operating profit was SEK -3.1 million (-7.6). Profit after tax was SEK -2.5 million (-7.3), and per share SEK -0.02 (-0.09). Order intake amounted to SEK 8.9 million (27.3), a decrease of 67.4 percent year-over-year. Cash flow from operating activities amounted to SEK -10.9 million (-3.1). Cash and cash equivalents amounted to SEK 30.0 million (27.2)."Overall, we have taken further steps in the right direction during the first half of the year. By far our most important task going forward is to strengthen our commercial focus on the customers and markets where we see the greatest potential, achieve more predictable and sustainable sales growth while maintaining clear cost control," comments CEO Lone CarlbomBio-Works, SEK millionQ2-2026Q2-2025ChangeOrder intake8.927.3-67.4%Net sales20.013.152.7%Operating profit-3.1-7.6Net profit-2.5-7.3Earnings per share, SEK-0.02-0.09Cash flow from operating activities-10.9-3.1Cash and cash equivalents30.027.210.3%